These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 16285984)

  • 1. Evaluation of microarray analysis for predicting treatment responsiveness in patients with chronic hepatitis C viral infection.
    Kim IJ; Kang HC; Park JG
    Gastroenterology; 2005 Nov; 129(5):1803; author reply 1803-4. PubMed ID: 16285984
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hepatitis C in 2007...progress and challenges].
    Marcellin P
    Gastroenterol Clin Biol; 2007; 31(8-9 Pt 3):4S3-6. PubMed ID: 17965628
    [No Abstract]   [Full Text] [Related]  

  • 3. Chronic viral hepatitis.
    Dakhil N; Junaidi O; Befeler AS
    Mo Med; 2009; 106(5):361-5. PubMed ID: 19902718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association with 5'-untranslated region and response to interferon in chronic hepatitis C.
    Katano Y; Hayashi K; Ishigami M; Itoh A; Hirooka Y; Nakano I; Goto H
    Hepatogastroenterology; 2007; 54(75):854-7. PubMed ID: 17591078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical application of microarray technique to quantify the lamivudine-resistant gene mutant of hepatitis B virus].
    Huang XT; Zeng AP; Lin F
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Jun; 21(2):185-7. PubMed ID: 17653332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chronic hepatitis C and B. What can be accomplished with antiviral therapy].
    MMW Fortschr Med; 2007 Feb; 149(7):14. PubMed ID: 17615650
    [No Abstract]   [Full Text] [Related]  

  • 7. APRI-M6 for predicting long-term outcome of chronic hepatitis C patients after interferon-based therapy: more questions than answers.
    Su TH; Kao JH; Chen DS
    Hepatology; 2007 Jun; 45(6):1586-7; author reply 1587-8. PubMed ID: 17538939
    [No Abstract]   [Full Text] [Related]  

  • 8. New therapies for hepatitis C virus infection.
    Soriano V; Peters MG; Zeuzem S
    Clin Infect Dis; 2009 Feb; 48(3):313-20. PubMed ID: 19123867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Present and future therapy for hepatitis C virus.
    Cornberg M; Deterding K; Manns MP
    Expert Rev Anti Infect Ther; 2006 Oct; 4(5):781-93. PubMed ID: 17140355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon regulatory factor-1 promoter polymorphism and the outcome of hepatitis C virus infection.
    Wietzke-Braun P; Maouzi AB; Mänhardt LB; Bickeböller H; Ramadori G; Mihm S
    Eur J Gastroenterol Hepatol; 2006 Sep; 18(9):991-7. PubMed ID: 16894313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving outcome in patients with hepatitis C virus genotype 4.
    Kamal SM
    Am J Gastroenterol; 2007 Nov; 102(11):2582-8. PubMed ID: 17900328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy.
    Yu ML; Chuang WL; Dai CY; Lee LP; Hsieh MY; Lin ZY; Chen SC; Hsieh MY; Wang LY; Chang WY; Tsai SL; Kuo HT
    Transl Res; 2006 Sep; 148(3):120-7. PubMed ID: 16938649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus viral load and treatment decision.
    Tillmann H; Patel K; McHutchison J
    Hepatology; 2009 Feb; 49(2):699; author reply 701-2. PubMed ID: 19177581
    [No Abstract]   [Full Text] [Related]  

  • 14. Review article: predicting response in hepatitis C virus therapy.
    Mihm U; Herrmann E; Sarrazin C; Zeuzem S
    Aliment Pharmacol Ther; 2006 Apr; 23(8):1043-54. PubMed ID: 16611264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Management of chronic hepatitis C in 2008].
    Pol S; Marcellin P
    Gastroenterol Clin Biol; 2008 Mar; 32(3 Pt 2):S121-4. PubMed ID: 18675182
    [No Abstract]   [Full Text] [Related]  

  • 16. Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy.
    Chehadeh W; Al-Nakib W
    J Med Virol; 2009 Apr; 81(4):610-8. PubMed ID: 19235842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Management of chronic viral hepatitis].
    Pache I; Mondada D; Moradpour D; Fontana M
    Rev Med Suisse; 2007 Jan; 3(95):215, 217-8, 221-3. PubMed ID: 17357690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of chronic hepatitis C virus infection - Dutch national guidelines.
    de Bruijne J; Buster EH; Gelderblom HC; Brouwer JT; de Knegt RJ; van Erpecum KJ; Schalm SW; Bakker CM; Zaaijer HL; Janssen HL; Reesink HW;
    Neth J Med; 2008; 66(7):311-22. PubMed ID: 18663263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of chronic hepatitis C. The Danish Society of Infection Medicine].
    Weis NM; Christensen PB; Laursen AL
    Ugeskr Laeger; 2006 Mar; 168(12):1221. PubMed ID: 16571312
    [No Abstract]   [Full Text] [Related]  

  • 20. Telaprevir: hope on the horizon, getting closer.
    Weisberg IS; Jacobson IM
    Clin Liver Dis; 2009 Aug; 13(3):441-52. PubMed ID: 19628160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.